Search

everythinglearnresearchcommunity

for

Search:↓

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Higher IL-17A levels indicate more severe alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.

The patient with lupus and Degos' disease showed significant improvement with treatment.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Hair follicles prevent NK cell attacks to avoid hair loss.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Specialist nurses play a crucial role in managing lupus and empowering patients.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.